13G Filing: Baker Bros. Advisors and Anacor Pharmaceuticals, Inc. (ANAC)

Page 4 of 10

Page 4 of 10 SEC Filing

 

CUSIP No.  032420101

1

NAMES
OF REPORTING PERSONS

 

Felix
J. Baker

 

2 CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)
¨  

(b)
¨  

 

3

SEC
USE ONLY

 

4

CITIZENSHIP
OR PLACE OF ORGANIZATION

 

United
States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

4,871,046

6

SHARED VOTING POWER

 

-0-

7

SOLE DISPOSITIVE POWER

 

4,871,046

8

SHARED DISPOSITIVE POWER

 

-0-

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON

 

4,871,046

10

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES

(See Instructions)

¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW 9

 

11.0% (1)

12

TYPE OF REPORTING PERSON (See Instructions)

IN, HC

 

(1) Based on 44,123,977 shares of common stock outstanding as of October 30, 2015, as reported in
the Issuer’s Form 10-Q filed with the SEC on November 6, 2015.
Page 4 of 10 Pages

Follow Anacor Pharmaceuticals Inc. (NASDAQ:ANAC)

Page 4 of 10